Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant
Recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effectiveness of CTX001 for Children with Severe Sickle Cell Disease Using Exagamglogene Autotemcel, Busulfan, and Plerixafor
Recruiting
Investigated Diseases:Investigated Drugs:
Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy
Recruiting
Investigated Diseases:Investigated Drugs:
powered by
